SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-21-051414
Filing Date
2021-04-16
Accepted
2021-04-16 17:09:56
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2113141d1_s3.htm S-3 521660
2 EXHIBIT 1.2 tm2113141d1_ex1-2.htm EX-1.2 273298
3 EXHIBIT 5.1 tm2113141d1_ex5-1.htm EX-5.1 35752
4 EXHIBIT 23.1 tm2113141d1_ex23-1.htm EX-23.1 2170
5 GRAPHIC tm2113141d1_s3sp1img01.jpg GRAPHIC 9018
6 GRAPHIC tm2113141d1s3img_001.jpg GRAPHIC 28230
7 GRAPHIC tm2113141d1_s3img04.jpg GRAPHIC 3904
8 GRAPHIC image_006.jpg GRAPHIC 74005
9 GRAPHIC tm2113141d1_img001.jpg GRAPHIC 7196
10 GRAPHIC image_007.jpg GRAPHIC 2970
  Complete submission text file 0001104659-21-051414.txt   1007640
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-255318 | Film No.: 21832330
SIC: 2834 Pharmaceutical Preparations